Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: A phase II trial (CALGB 8944)

G. G. Kimmick, C. Cirrincione, D. B. Duggan, K. Bhalla, N. Robert, D. Berry, L. Norton, S. Lemke, I. C. Henderson, C. Hudis, E. Winer

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: A phase II trial (CALGB 8944)'. Together they form a unique fingerprint.

Medicine & Life Sciences